Nanomedicines against Chagas disease: a critical review

• Maria Jose Morilla,
• Kajal Ghosal and
• Eder Lilia Romero

Beilstein J. Nanotechnol. 2024, 15, 333–349, doi:10.3762/bjnano.15.30

• implemented in India in the mid-1990s is an excellent example [61][62]. Amphotericin B binds to parasite ergosterol precursors, such as lanosterol, disrupting the parasite membrane. Since protozoan trypanosomatids such as Leishmania and Trypanosoma present ergosterol as a component of their membranes [63

• liposomes”, “cruzi and nanoparticles”, “cruzi and micelles”; “leishmania and liposomes”, “leishmania and nanoparticles”, “leishmania and micelles”; “malaria and liposomes”, “malaria and nanoparticles”, “malaria and micelles”, “plasmodium and liposomes”, “plasmodium and nanoparticles”, and “plasmodium and

Curcumin-loaded nanostructured systems for treatment of leishmaniasis: a review

• Douglas Dourado,
• Thayse Silva Medeiros,
• Éverton do Nascimento Alencar,
• Edijane Matos Sales and
• Fábio Rocha Formiga

Beilstein J. Nanotechnol. 2024, 15, 37–50, doi:10.3762/bjnano.15.4

• Leishmania spp. Although its mechanism of action has not yet been fully elucidated, its leishmanicidal potential may be associated with its antioxidant and anti-inflammatory properties. However, it has limitations that compromise its clinical use. Conversely, nanotechnology has been used as a tool for

• vector-borne protozoan parasite of the genus Leishmania which is transmitted by the bite of female sandflies. Different species of Leishmania spp. can cause specific clinical manifestations. These are (i) cutaneous leishmaniasis, which can be the localized type when the lesions are limited to certain

• high tolerance profile, and it has shown in vitro and in vivo leishmanicidal properties against different species of Leishmania spp. [11][14]. Despite its pharmacological potential, curcumin has some physicochemical and biopharmaceutical limitations that should be highlighted, such as: (i) low aqueous

Green SPIONs as a novel highly selective treatment for leishmaniasis: an in vitro study against Leishmania amazonensis intracellular amastigotes

• Brunno R. F. Verçoza,
• Robson R. Bernardo,
• Luiz Augusto S. de Oliveira and
• Juliany C. F. Rodrigues

Beilstein J. Nanotechnol. 2023, 14, 893–903, doi:10.3762/bjnano.14.73

• The main goal of this work was to evaluate the therapeutic potential of green superparamagnetic iron oxide nanoparticles (SPIONs) produced with coconut water for treating cutaneous leishmaniasis caused by Leishmania amazonensis. Optical and electron microscopy techniques were used to evaluate the

• current drugs used to treat the disease. The synthesized SPIONs showed promising activity against Leishmania and can be considered a strong candidate for a new therapeutic approach for treating leishmaniases. Keywords: coconut water; Leishmaniasis; Leishmania amazonensis; nanomedicine; SPIONs

• and less toxic to the patient. Thus, the main goal of this study is to evaluate the effects of green SPIONs against Leishmania amazonensis (L. amazonensis) in vitro. Results Uptake of SPIONs by L. amazonensis promastigotes and intracellular amastigotes Bright-field optical microscopy of L. amazonensis

Supramolecular assembly of pentamidine and polymeric cyclodextrin bimetallic core–shell nanoarchitectures

• Alexandru-Milentie Hada,
• Nina Burduja,
• Marco Abbate,
• Claudio Stagno,
• Guy Caljon,
• Louis Maes,
• Nicola Micale,
• Massimiliano Cordaro,
• Angela Scala,
• Antonino Mazzaglia and
• Anna Piperno

Beilstein J. Nanotechnol. 2022, 13, 1361–1369, doi:10.3762/bjnano.13.112

• during the reduction/stabilization of metal NPs was investigated for the first time by NMR spectroscopy. Keywords: antimicrobial agents; bimetallic nanoparticles; gold/silver core–shell; Leishmania; pentamidine; polycyclodextrin; Introduction Noble metal nanoparticles (NPs), in particular those